SCHEMBL20371973

SCHEMBL20371973

Cc1ccccc1-c1cnc(C)c(CC(=O)O)c1N1CCC(C)(C)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN2B Q13224 6/20 0.35
▸ CYP11B2 P19099 1/20 0.33
▸ MEN1 O00255 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ CYP1A2 P05177 2/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KCNQ2 O43526 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ PTPN11 Q06124 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.32
▸ SLC6A7 Q99884 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ OPRM1 P35372 1/20 0.32
▸ OPRD1 P41143 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20372216 0.90 PTGDR2 (0.38) GRIN2BALDH1A1KDM4EGAAPTGDR2
SCHEMBL20372251 0.90 GRIN2B (0.41) GRIN2BPTPN11
SCHEMBL20371960 0.89 PTGDR2 (0.38) GRIN2BCYP3A4CYP2D6ALDH1A1KDM4E
SCHEMBL20372333 0.89 DPP4 (0.36) CYP11B2ALDH1A1PTPN11
SCHEMBL20372078 0.88 PPARD (0.38) MEN1KMT2ACYP1A2CYP3A4CYP2D6
SCHEMBL20372217 0.86 LMNA (0.35) GRIN2BALDH1A1PTPN11SMN1; SMN2
SCHEMBL20372255 0.85 CYP46A1 (0.37) KMT2ACYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL20372260 0.84 PDE9A (0.33) MEN1KMT2ACYP3A4ALDH1A1KCNQ2
SCHEMBL20372489 0.84 KCNH2 (0.34) GRIN2BCYP3A4ALDH1A1KCNQ2PTPN11
SCHEMBL20372093 0.84 PTPN11 (0.41) GRIN2BPTPN11SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018127800-A1 PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2018-07-12 — — WO disclosed
Send feedback